Related Experiment Video
Updated: Aug 11, 2026
18:01
Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants
Published on: August 18, 2008
Summary
Serotonin stimulates motility and carbohydrate metabolism in parasitic flatworms by activating specific receptors linked to cyclic AMP production. This pathway offers potential targets for new anti-parasitic drugs.
Area of Science:
- Parasitology
- Neuroendocrinology
- Biochemistry
Background:
- Serotonin's role in parasitic worms has garnered significant interest.
- Previous studies showed serotonin affects motility and carbohydrate metabolism in *Fasciola hepatica*.
Purpose of the Study:
- To review and synthesize the current understanding of serotonin's action in parasitic worms.
- To investigate the biochemical mechanisms of serotonin signaling in platyhelminths and nematodes.
- To explore the potential of serotonin receptors as therapeutic targets.
Main Methods:
- Review of existing literature on serotonin in parasitic worms.
- Biochemical analysis of serotonin receptors and adenylate cyclase activity in *F. hepatica* and *Schistosoma mansoni*.
- Investigation of cyclic AMP signaling pathways.
Main Results:
- Serotonin consistently stimulates motility in platyhelminths and glycogenolysis in studied flatworms.
- Serotonin receptors linked to adenylate cyclase and cyclic AMP (cAMP) production were identified in *F. hepatica* and *S. mansoni*.
- cAMP activates key enzymes in glycogenolysis and glycolysis, potentially influencing parasite development.
Conclusions:
- Serotonin signaling via cAMP is a conserved pathway in parasitic flatworms.
- Differences in serotonin receptor binding between parasites and hosts present opportunities for selective drug development.
- Targeting parasite serotonin receptors could lead to novel chemotherapeutic strategies.
Related Concept Videos
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:28Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
01:18Trichomoniasis
Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...